This Policy applies to residents of the United States. Assertio Therapeutics, Inc. (“Assertio”) respects the privacy of information that it obtains from visitors to this website (this “Site”). It is Assertio’s intention to balance its legitimate business interests in collecting and using information received from and about you with your reasonable expectations of privacy.
Assertio collects certain personally identifiable information including your name, address, email address and phone number only when provided by you for the purpose of responding to your requests for information. Assertio also collects anonymous information about the use of our Site, such as the number of visitors, the length and time of their visits, the pages they view, the web browsers they use, etc. Such anonymous data may be used by Assertio and disclosed by Assertio to third parties to improve this Site and to better understand your needs.
Assertio does not intentionally collect information about children under the age of thirteen. If you are under thirteen, please do not give Assertio any personal data.
Assertio does not disclose any personally identifiable information about you to any third parties except under the following circumstances:
- Assertio will provide your information to a third party if you specifically agree that Assertio may provide your information to a third party.
- Assertio may use a third-party service provider to assist with sending information you request from us by email, mail or other means.
- Assertio may need to disclose your personally identifiable information when required by law or if it has a good-faith belief that such action is necessary to comply with a court order or subpoena, to cooperate with investigations by law enforcement or regulatory authorities or to participate or cooperate with a judicial proceeding.
- In a merger, acquisition by another company or a sale of all or a portion of our assets, your personal information will, in most instances, be transferred to the control of a third party.
Last revised: August 15, 2018